Collaboration Creates Impact
SU2C’s approach centers on collaborative research addressing unmet needs across all cancer types. By supporting us, you drive forward the future of cancer research and care.
At SU2C, collaboration is in our DNA, uniting the brightest minds for a common purpose. Our collaborators include:
SU2C prioritizes collaborative research that leverages the latest technologies to detect and stop all cancers, and close gaps in health equity via:
- Early-stage detection and interception powered by AI and large language model computing
- Cancer vaccines and immunotherapies
- An emphasis on difficult to treat cancers
SU2C uses the breadth and depth of our reach in the media and entertainment industries to inform and empower the public. We spread the word about the importance of cancer screenings and preventive care, encourage participation in clinical trials, and give survivors a platform to share their stories through:
- Public relations, public service announcements, televised specials, and film and TV integrations
- Digital Marketing
- Donor and community collaborations
Building a Better Future
It will take more than great science and technology to make early-stage detection the standard of care.
It will take a movement. And this movement needs you.
SU2C is a movement driven by collaboration. We have the expertise, visibility, and network to focus the nation’s attention on early-stage detection and transform the standards of prevention and care for all cancers. With your support, we will:
Our Funding Model
SU2C’s model focuses on collaborative research on unmet needs in all cancers. By supporting SU2C, you help transform the future of cancer research and care. We amplify the impact of donor support to accelerate research for everyone impacted by cancer.
